+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Intravenous Therapy & Vein Access Devices Market by Device Type (Central Catheter, Hemodialysis Catheter, Implanted Port), Application (Anesthesia, Blood Sampling, Critical Care), Material, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6142005
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

How Cutting Edge Innovations Converge with Clinical Protocols to Redefine Safety and Efficiency in Intravenous Therapy Devices

The dynamic realm of intravenous therapy and vein access devices is witnessing a convergence of technological breakthroughs, evolving clinical protocols, and heightened patient expectations. Innovations in catheter designs and materials have elevated the standard of care, mitigating risks of infection and thrombosis while enhancing procedural efficiency. At the same time, regulatory scrutiny and healthcare cost pressures are driving stakeholders to adopt safe, cost-effective solutions that improve patient outcomes across diverse care environments.

In this executive summary, we illuminate the strategic forces that are reshaping the market for central catheters, peripheral lines, implanted ports, and advanced midline devices. We explore how customization of device configurations for oncology infusions and parenteral nutrition is unlocking new therapeutic possibilities. Moreover, we highlight the critical role of interdisciplinary collaboration among nurses, interventional radiologists, and vascular access specialists in ensuring seamless device insertion and maintenance. Through this lens, readers will gain a comprehensive understanding of the market’s current dynamics and the emerging opportunities that will define its trajectory in the coming years.

Pioneering Digital Integration and Advanced Materials Set New Standards for Safety Efficacy and Cost Efficiency in Vein Access Devices

The market landscape has been transformed by the integration of digital health solutions, material science advancements, and patient-centric design principles. Smart infusion pumps equipped with real-time monitoring capabilities are increasingly interfaced with electronic health records, enabling clinicians to detect occlusions and pressure anomalies that could compromise patient safety. Concurrently, the introduction of antimicrobial and antithrombogenic coatings on catheter surfaces is significantly reducing the incidence of bloodstream infections, thereby lowering hospitalization costs and improving survival rates among vulnerable patient populations.

Notably, 3D printing technologies are enabling rapid prototyping of patient-specific vascular access devices, which is revolutionizing approaches to complex anatomies and urgent care scenarios. In parallel, the shift toward value-based care models has prompted providers to prioritize devices that demonstrate clinical efficacy and cost-effectiveness through robust health economic evidence. As a result, collaborations between device manufacturers and payers are intensifying to validate real-world performance and secure favorable reimbursement pathways. These transformative shifts are setting a new benchmark for quality, safety, and innovation across care settings worldwide.

Strategic Localization and Agile Supply Chain Approaches Mitigate the Effects of United States Tariff Adjustments on Intravenous Device Costs

The implementation of refreshed tariff measures in 2025 has introduced new cost variables for raw materials, components, and finished intravenous therapy devices imported into the United States. In response, industry players are reevaluating their global sourcing strategies to mitigate exposure to increased duties on polymers and specialized tubing, while also pursuing alternative supply chain configurations that ensure continuity of supply. These adjustments have spurred greater localization of production, with manufacturers exploring joint ventures and strategic partnerships in North American markets to alleviate duty burdens and streamline logistics.

In addition, the tariff-induced cost pressures have catalyzed innovations in material selection and device assembly methods. Suppliers are collaborating with research institutions to develop lower-cost yet high-performance polymers that comply with stringent biocompatibility standards without inflating end-user prices. Furthermore, manufacturers are refining lean manufacturing protocols to absorb tariff-related expenses through waste reduction, yield improvement, and optimized inventory management. By embracing agility in procurement and production processes, stakeholders are successfully safeguarding profit margins while maintaining competitive pricing for hospitals, clinics, and home care providers.

Unveiling Market Dynamics Across Device Types Applications Materials and End User Environments Driving Targeted Intravenous Therapy Solutions

The analysis of market segmentation reveals distinct growth trajectories and areas of innovation based on device typology. Central catheters, including peripherally inserted central catheters and tunneled central catheters, remain focal points for oncology infusions and long-term critical care due to their reliability and sustained patency. Meanwhile, peripheral catheters and midline catheters are gaining traction in short-term therapy settings where rapid insertion and reduced complication rates are paramount. Nerve block catheters are emerging as specialized solutions in regional anesthesia, offering precision delivery of analgesics to targeted neural pathways.

Diving deeper into application segments, drug administration continues to account for the majority of device utilization, while oncology and parenteral nutrition segments are experiencing heightened demand driven by personalized treatment protocols. On the material front, polyurethane has become the preferred substrate for flexible venous access devices, whereas silicone is favored for its softness and compatibility in tunneled applications. Polytetrafluoroethylene remains a niche material in hemodialysis catheter manufacturing, recognized for its superior chemical resistance. In terms of end users, hospital settings dominate volume consumption, but home care environments and ambulatory surgical centers are witnessing accelerated adoption as care delivery models evolve toward decentralization.

Comparative Regional Landscape Illustrating Distinct Healthcare Imperatives and Device Adoption Patterns Across Global Markets

Regional dynamics within the intravenous therapy and vein access devices market illustrate varied adoption rates and strategic initiatives across the Americas, Europe Middle East and Africa, and Asia-Pacific territories. In the Americas, demand is propelled by large healthcare networks investing in advanced infusion systems and comprehensive vascular access programs aimed at reducing complications and readmissions. Collaborative research endeavors between academic medical centers and industry players are driving the development of next-generation catheters tailored to bariatric and bariatric-adjacent patient populations.

Across Europe, Middle East and Africa, stringent regulatory frameworks and pan-regional healthcare initiatives are shaping procurement strategies. Governments are prioritizing devices that demonstrate strong safety profiles and longevity to curb healthcare expenditures. Meanwhile, private healthcare facilities in the Gulf Cooperation Council are investing heavily in premium vascular access solutions to meet growing oncology and intensive care needs. In the Asia-Pacific region, expanding healthcare infrastructure in emerging economies is spurring local production capabilities, with manufacturers targeting cost-sensitive segments by introducing tiered product lines. In mature markets like Japan and Australia, ongoing modernization of infusion therapy protocols is fueling demand for integrated monitoring solutions and specialized catheter technologies.

How Strategic Collaborations and Innovation Ecosystems Propel Competitive Advantage and Drive Product Evolution Among Leading Intravenous Device Manufacturers

Key industry participants are advancing their competitive positions through strategic product launches, mergers and acquisitions, and targeted partnerships. Leading medical device conglomerates are bolstering their intravenous therapy portfolios with antimicrobial and pressure-sensing catheters, while specialized niche players are focusing on high-purity polymer development and bespoke device manufacturing services. Several prominent manufacturers have established innovation hubs that facilitate collaboration with clinical investigators to accelerate product iterations and secure regulatory clearances.

Moreover, cross-sector alliances between device firms and digital health specialists are generating integrated solutions that combine catheter technology with telemonitoring platforms. This synergy is enabling remote patient management programs that reduce hospital visits and enhance post-discharge care. At the same time, contract manufacturing organizations are scaling capabilities to meet just-in-time production demands and support rapid product rollouts. These multifaceted strategies are intensifying competition, driving consolidation, and inspiring a wave of technological advancements that will shape the future of intravenous therapy and vein access devices.

Actionable Strategic Imperatives for Device Creators to Enhance Clinical Integration and Secure Reimbursement in a Value Driven Healthcare Landscape

Industry leaders should strengthen their value propositions by deepening collaborations with clinical end users to co-develop solutions that address real-world procedural challenges. By integrating feedback loops into product development lifecycles, device developers can refine ergonomics, workflow integration, and safety features that resonate with practitioners. A diversified sourcing strategy that balances global procurement efficiency with localized manufacturing agility will be essential for mitigating tariff-related risks and optimizing cost structures.

Furthermore, investing in robust health economic studies and real-world evidence generation will bolster reimbursement discussions and accelerate market access. To capitalize on the digital transformation trend, companies should explore partnerships with software developers to embed connectivity features within catheters and infusion systems, creating differentiated offerings that support remote monitoring. By aligning strategic roadmaps with emerging regulatory trends and payer priorities, industry players will position themselves to capture growth opportunities and sustain margins in an increasingly value-driven marketplace.

Rigorous Mixed Method Research Approach Integrating Primary Expert Interviews and Multisource Secondary Analysis to Validate Key Market Insights

This report’s findings are grounded in a comprehensive research methodology that combines primary and secondary data collection processes. Primary research involved structured interviews with key opinion leaders, including interventional radiologists, vascular access nurses, procurement managers, and industry executives, to capture firsthand insights into device performance, clinical adoption drivers, and development roadmaps. Secondary research encompassed a detailed examination of regulatory filings, patent databases, clinical trial registries, peer-reviewed journals, and industry whitepapers to validate market trends and technological advancements.

Data triangulation techniques were applied to reconcile information from diverse sources, ensuring consistency and reliability in the analysis. Quantitative analyses were enriched by qualitative assessments of risk factors, regulatory landscapes, and competitive dynamics. Rigorous data quality checks and peer reviews were conducted throughout the research process to maintain methodological integrity. These robust approaches provide a solid foundation for the strategic and operational recommendations presented in this summary.

Synthesis of Market Dynamics Underscores the Imperative for Collaborative Innovation and Adaptive Strategies in Vein Access and Intravenous Therapy Devices

The evolving landscape of intravenous therapy and vein access devices presents both opportunities and challenges for stakeholders across the value chain. Technological advancements in materials science, smart monitoring, and procedural standardization are setting new performance benchmarks while regulatory and cost pressures necessitate agile business models. The interplay of these factors is reshaping clinical practices, driving regional market differentiation, and fueling innovation within established and emerging device categories.

As healthcare systems continue to prioritize patient safety, operational efficiency, and cost containment, the onus is on device manufacturers to deliver solutions that demonstrate clear value propositions through robust clinical evidence and economic benefits. Stakeholders who embrace collaborative innovation, strategic supply chain management, and data-driven decision making will be best positioned to navigate the complexities of this dynamic market and secure sustainable growth in the years ahead.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Device Type
    • Central Catheter
      • Peripherally Inserted Central Catheter
      • Tunneled Central Catheter
    • Hemodialysis Catheter
    • Implanted Port
    • Midline Catheter
    • Nerve Block Catheter
    • Peripheral Catheter
  • Application
    • Anesthesia
    • Blood Sampling
    • Critical Care
    • Drug Administration
    • Oncology
    • Parenteral Nutrition
  • Material
    • Polytetrafluoroethylene
    • Polyurethane
    • Polyvinyl Chloride
    • Silicone
  • End User
    • Ambulatory Surgical Centers
    • Clinics
    • Home Care Settings
    • Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius SE & Co. KGaA
  • Terumo Corporation
  • ICU Medical, Inc.
  • Smiths Group plc
  • Nipro Corporation
  • Teleflex Incorporated
  • AngioDynamics, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of ultrasound-guided peripheral IV insertion to improve first-attempt success rates
5.2. Growing implementation of smart infusion pumps with integrated dose-error reduction systems for safer medication delivery
5.3. Surging use of antimicrobial- and silver-coated catheters to mitigate catheter-related bloodstream infections in hospitals
5.4. Expansion of home-based intravenous therapy services driven by telehealth monitoring and patient convenience demands
5.5. Increasing preference for midline catheters in oncology and long-term antibiotic patients to minimize central line complications
5.6. Integration of IoT-enabled analytics in infusion devices for real-time monitoring and predictive maintenance of equipment
5.7. Development of eco-friendly IV packaging materials and disposable components to address healthcare sustainability goals
5.8. Advancements in simulation-based training modules enhancing nurse proficiency in difficult vein access scenarios
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Intravenous Therapy & Vein Access Devices Market, by Device Type
8.1. Introduction
8.2. Central Catheter
8.2.1. Peripherally Inserted Central Catheter
8.2.2. Tunneled Central Catheter
8.3. Hemodialysis Catheter
8.4. Implanted Port
8.5. Midline Catheter
8.6. Nerve Block Catheter
8.7. Peripheral Catheter
9. Intravenous Therapy & Vein Access Devices Market, by Application
9.1. Introduction
9.2. Anesthesia
9.3. Blood Sampling
9.4. Critical Care
9.5. Drug Administration
9.6. Oncology
9.7. Parenteral Nutrition
10. Intravenous Therapy & Vein Access Devices Market, by Material
10.1. Introduction
10.2. Polytetrafluoroethylene
10.3. Polyurethane
10.4. Polyvinyl Chloride
10.5. Silicone
11. Intravenous Therapy & Vein Access Devices Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Home Care Settings
11.5. Hospitals
12. Americas Intravenous Therapy & Vein Access Devices Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Intravenous Therapy & Vein Access Devices Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Intravenous Therapy & Vein Access Devices Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Becton, Dickinson and Company
15.3.2. B. Braun Melsungen AG
15.3.3. Baxter International Inc.
15.3.4. Fresenius SE & Co. KGaA
15.3.5. Terumo Corporation
15.3.6. ICU Medical, Inc.
15.3.7. Smiths Group plc
15.3.8. Nipro Corporation
15.3.9. Teleflex Incorporated
15.3.10. AngioDynamics, Inc.
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET: RESEARCHAI
FIGURE 24. INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET: RESEARCHSTATISTICS
FIGURE 25. INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET: RESEARCHCONTACTS
FIGURE 26. INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY TUNNELED CENTRAL CATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY TUNNELED CENTRAL CATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY HEMODIALYSIS CATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY HEMODIALYSIS CATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY IMPLANTED PORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY IMPLANTED PORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY NERVE BLOCK CATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY NERVE BLOCK CATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY PERIPHERAL CATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY PERIPHERAL CATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY ANESTHESIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY BLOOD SAMPLING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY BLOOD SAMPLING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CRITICAL CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY SILICONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY SILICONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 87. CANADA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 88. CANADA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 89. CANADA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 90. CANADA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 91. CANADA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. CANADA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. CANADA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 94. CANADA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 95. CANADA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. CANADA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. MEXICO INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 98. MEXICO INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 99. MEXICO INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 100. MEXICO INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 101. MEXICO INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. MEXICO INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. MEXICO INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 104. MEXICO INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 105. MEXICO INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. MEXICO INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 140. UNITED KINGDOM INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. GERMANY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 150. GERMANY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 151. GERMANY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 152. GERMANY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 153. GERMANY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. GERMANY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. GERMANY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 156. GERMANY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 157. GERMANY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. GERMANY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. FRANCE INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 160. FRANCE INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 161. FRANCE INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 162. FRANCE INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 163. FRANCE INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. FRANCE INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. FRANCE INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 166. FRANCE INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 167. FRANCE INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. FRANCE INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. RUSSIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 170. RUSSIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 171. RUSSIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 172. RUSSIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 173. RUSSIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. RUSSIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. RUSSIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 176. RUSSIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. ITALY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 180. ITALY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 181. ITALY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 182. ITALY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 183. ITALY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. ITALY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. ITALY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 186. ITALY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 187. ITALY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. ITALY INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. SPAIN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 190. SPAIN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 191. SPAIN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 192. SPAIN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 193. SPAIN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. SPAIN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. SPAIN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 196. SPAIN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 197. SPAIN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. SPAIN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 210. SAUDI ARABIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 212. SAUDI ARABIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. SAUDI ARABIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 216. SAUDI ARABIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. SAUDI ARABIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 220. SOUTH AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 222. SOUTH AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. SOUTH AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 226. SOUTH AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. SOUTH AFRICA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. DENMARK INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 230. DENMARK INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 231. DENMARK INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 232. DENMARK INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 233. DENMARK INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. DENMARK INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. DENMARK INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 236. DENMARK INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 237. DENMARK INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. DENMARK INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. NETHERLANDS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 240. NETHERLANDS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 241. NETHERLANDS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 242. NETHERLANDS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 243. NETHERLANDS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. NETHERLANDS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. NETHERLANDS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 246. NETHERLANDS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 247. NETHERLANDS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. NETHERLANDS INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. QATAR INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 250. QATAR INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 251. QATAR INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 252. QATAR INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 253. QATAR INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. QATAR INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. QATAR INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 256. QATAR INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 257. QATAR INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. QATAR INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. FINLAND INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 260. FINLAND INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 261. FINLAND INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 262. FINLAND INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 263. FINLAND INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. FINLAND INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. FINLAND INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 266. FINLAND INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 267. FINLAND INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. FINLAND INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. SWEDEN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 270. SWEDEN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 271. SWEDEN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2018-2024 (USD MILLION)
TABLE 272. SWEDEN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY CENTRAL CATHETER, 2025-2030 (USD MILLION)
TABLE 273. SWEDEN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. SWEDEN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. SWEDEN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 276. SWEDEN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 277. SWEDEN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. SWEDEN INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. NIGERIA INTRAVENOUS THERAPY & VEIN ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 280.

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Intravenous Therapy & Vein Access Devices Market report include:
  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius SE & Co. KGaA
  • Terumo Corporation
  • ICU Medical, Inc.
  • Smiths Group plc
  • Nipro Corporation
  • Teleflex Incorporated
  • AngioDynamics, Inc.